tiprankstipranks
AngioDynamics downgraded to Outperform from Strong Buy at Raymond James
The Fly

AngioDynamics downgraded to Outperform from Strong Buy at Raymond James

Raymond James analyst Jayson Bedford downgraded AngioDynamics to Outperform from Strong Buy with a price target of $13, down from $14. Uncertainties around potential liabilities are largely factored into the stock price, but this overhang should continue to weigh on sentiment until a resolution appears, the analyst tells investors in a research note. The firm believes there is more value in the business and hopes that the board will pursue more "creative" paths for value creation.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on ANGO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles